Promoting productive interactions between parents and physicians in the treatment of children with

William B Brinkman1, Jeffery N Epstein

  • 1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. bill.brinkman@cchmc.org

Insights

Attention-deficit/hyperactivity disorder (ADHD) requires chronic care management. Effective parent-physician collaboration is key for optimizing treatment and addressing barriers in primary care settings.

Area of Science:

  • Neurobehavioral health
  • Pediatric chronic condition management

Background:

  • Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurobehavioral condition impacting children and adolescents.
  • Evidence-based guidelines advocate for viewing ADHD as a chronic condition requiring ongoing management.
  • The chronic care model highlights the importance of family-provider partnerships in managing childhood health conditions.

Purpose of the Study:

  • To review recommended physician-parent interactions for ADHD care.
  • To examine current practice patterns in ADHD management.
  • To identify facilitators and barriers to implementing best practices in ADHD care.

Main Methods:

  • Literature review of evidence-based guidelines for ADHD treatment.
  • Analysis of key parent-physician interactions in ADHD management.
  • Examination of care delivery in community-based primary care settings.

Main Results:

  • Key interactions include family education, goal setting, treatment planning, screening, and monitoring.
  • Primary care settings face significant barriers to providing high-quality chronic care for ADHD.
  • Current practice patterns often fall short of recommended chronic care standards.

Conclusions:

  • Optimizing ADHD care necessitates strong parent-physician collaboration within a chronic care framework.
  • Addressing systemic barriers in primary care is crucial for improving ADHD management.
  • Implementing recommended practices can enhance functional outcomes for children with ADHD.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
823
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
446